301 related articles for article (PubMed ID: 20387288)
1. Clinical use of sildenafil in pulmonary artery hypertension.
Singh TP
Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil in the treatment of pulmonary hypertension.
Barnett CF; Machado RF
Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension.
Behzadnia N; Najafizadeh K; Sharif-Kashani B; Dameshghi DO; Shahabi P
Heart Vessels; 2010 Jul; 25(4):313-8. PubMed ID: 20676840
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil for the treatment of pulmonary hypertension in pediatric patients.
Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES
Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.
Wilkens H; Guth A; König J; Forestier N; Cremers B; Hennen B; Böhm M; Sybrecht GW
Circulation; 2001 Sep; 104(11):1218-22. PubMed ID: 11551870
[TBL] [Abstract][Full Text] [Related]
6. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S
Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.
Porta NF; Steinhorn RH
Clin Perinatol; 2012 Mar; 39(1):149-64. PubMed ID: 22341543
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
Leibovitch L; Matok I; Paret G
Drugs; 2007; 67(1):57-73. PubMed ID: 17209664
[TBL] [Abstract][Full Text] [Related]
9. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.
El Midany AA; Mostafa EA; Azab S; Hassan GA
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):963-8. PubMed ID: 23985411
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
[TBL] [Abstract][Full Text] [Related]
12. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D
Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil?
Ng J; Finney SJ; Shulman R; Bellingan GJ; Singer M; Glynne PA
Br J Anaesth; 2005 Jun; 94(6):774-7. PubMed ID: 15764630
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary arterial hypertension. Physiopathology, genetic aspects and response to the chronic use of sildenafil].
Barreto AC; Franchi SM; Pereira AC; Lopes AA
Arq Bras Cardiol; 2005 Aug; 85(2):147-54. PubMed ID: 16113857
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil 20 mg. Pulmonary arterial hypertension: for oral treatment, no better than bosentan.
Prescrire Int; 2006 Dec; 15(86):221. PubMed ID: 17167928
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil: a review of its use in pulmonary arterial hypertension.
Croom KF; Curran MP
Drugs; 2008; 68(3):383-97. PubMed ID: 18257613
[TBL] [Abstract][Full Text] [Related]
19. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with oral sildenafil and beraprost for pulmonary arterial hypertension associated with CREST syndrome.
Miwa K; Matsubara T; Uno Y; Yasuda T; Sakata K; Tsuda T; Kanaya H
Int Heart J; 2007 May; 48(3):417-22. PubMed ID: 17592207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
